Please provide your email address to receive an email when new articles are posted on . The FDA approved a mapping and dual-energy catheter ablation system for treatment of persistent AF. The system ...

Please provide your email address to receive an email when new articles are posted on . Biosense Webster announced the launch of an FDA-cleared catheter with novel technology for mapping cardiac ...

The OCTARAY™ Mapping Catheter with TRUEref™ Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac ...

Stereotaxis STXS, a global leader in surgical robotics for minimally invasive endovascular intervention, recently announced the successful completion of the first U.S. commercial procedures using its ...

Stereotaxis has received US Food and Drug Administration (FDA) clearance for MAGiC Sweep, an electrophysiology (EP) catheter. Shares in the company rose by 10.66% from $2.25 at market close on 25 July ...

Industry's highest density fixed array mapping catheter, covering the largest area in a fixed matrix format, can help physicians effectively map in a shorter procedure time "The OPTRELL™ Mapping ...

The FDA-approved catheters will be used with a mapping system that creates a computer model of the patient's heart. BOSTON SCIENTIFIC Marlborough’s Boston Scientific has received U.S. Food and Drug ...

Only a few months after Medtronic completed its acquisition of cardiac device maker Affera, the nearly billion-dollar buyout is already paying off. A dual-use catheter originally developed by Affera ...

Surgical robotics leader Stereotaxis has earned FDA clearance for its MAGiC Sweep catheter, the world’s first robotically navigated high-density electrophysiology mapping catheter. The catheter marks ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Kardium is pleased to announce the first clinical use of the Globe Positioning System (GPS™) – the new 3D mapping and navigation feature of its flagship ...

Innovative Technology Designed to Optimize Arctic Front® Cardiac CryoAblation Catheter System in the Treatment of Paroxysmal Atrial Fibrillation MINNEAPOLIS, USA and TOLOCHENAZ, SWITZERLAND – ...

New Technology Adds Diagnostic Capability to the Arctic Front® Cardiac CryoAblation Catheter System in Treating Paroxysmal Atrial Fibrillation MINNEAPOLIS, Medtronic, Inc. today announced the U.S.